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SfII is a serotype-converting temperate bacteriophage of the highly prevalent Shigella flexneri serotype 2a. We isolated the SfII
phage from a wild-type strain of S. flexneri serotype 2a. Here, we present the complete genome sequence of this phage.
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Shigella flexneri strains are most frequently linked with out-breaks of shigellosis, and these strains are susceptible to infec-
tion by temperate lambdoid bacteriophages.Here, we isolated and
completely sequenced bacteriophage SfII, induced from a virulent
S. flexneri 2a serotype, strain NCTC 4. S. flexneri 2a is the most
widespread serotype associated with shigellosis cases (1).
Electron microscopy data (2) show that SfII morphologically re-
sembles bacteriophagesbelonging to groupA1, fromthe familyMyo-
viridae and the order Caudovirales (3). SfII confers its host with the
serotype-converting O-antigen-modifying glucosyltransferase (gtr)
genes. Serotype conversion is a key defense mechanism used by
S. flexneri to evade host defense responses (4). Not much is known
about temperate bacteriophages of S. flexneri outside their role in
serotype conversion.
To further our understanding of S. flexneri phages, the com-
plete sequence of SfII was determined. Eight PstI fragments gen-
erated from the SfII genome were cloned individually into a
pBlueScript vector, and both strands of each fragment were then
sequenced using Sanger sequencing. Primer walking was used to
fill in gaps and determine the order of the fragments. The DNA
sequences were assembled into contigs using BioEdit (5). Putative
open reading frames (ORFs) were identified using the NCBI ORF
Finder and CLC Main Workbench version 6.5.
The genome of SfII is linear, double-stranded, and is 41,475 bp
with an average GC content of 49.17%, corresponding to 58
coding sequences (CDSs). Most of the genome (71.57%) is pre-
dicted to be transcribed from the sense strand, while 19.14%of the
genome, including the gtr cluster, is predicted to be transcribed by
the antisense strand. In database searches of the 58 predictedORFs
using NCBI BLASTx, 41 were assigned functions and 17 were
identified as hypothetical proteins.
Nucleotide and protein homology searches with other pub-
lished S. flexneri phage genomes indicate that SfII, like SfV (6), SfI
(7), and Sf6 (8), is a member of the temperate lambdoid group of
bacteriophages with their conserved arrangements of early and
late genes. A comparison of phage terminases found that the pack-
aging mechanism used by SfII is similar to those of SfV and SfI,
with cohesive end (cos) sites spanning bp 59 to 125, adjacent to the
terminases. Although SfII contains features of SfV and SfI, it has a
unique host range. While SfV was capable of infecting 7 of the 12
S. flexneri serotypes tested (serotypes 1a, 1b, 2a, 2b, 3b, 4b, and Y),
SfII and SfI only infected 3 (serotypes 3b, 5a, and Y) and 2 (sero-
types X and Y) of the 12 serotypes tested, respectively.
Themain differences between S. flexneri SfII, SfV, and SfI lie in
their immunity, replication, and Nin regions. Our analysis found
the following genes to be unique to SfII: SfII_25 (acyltransferase),
SfII_27 (gtrII), SfII_26, SfII_55, and SfII_56 (transposases),
SfII_35, SfII_36, SfII_40, SfII_41, SfII_49, SfII_ 50, and SfII_57
(hypothetical proteins), and SfII_48 (antiterminator Q). It will be
interesting to study the hypothetical proteins that are unique to
SfII in the context of Shigella pathogenesis.
Nucleotide sequence accession number.The complete ge-
nome sequence of bacteriophage SfII has been deposited in Gen-
Bank under the accession no. KC736978.
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